ACER1 is on the list of in-frame reciprocal KMT2A partners - and ACER1 is the gene the 'reciprocal-negative' breakpoints fall next to
also called ACER1::KMT2A · ACER1-KMT2A reciprocal fusion · spliced fusion reciprocal exception
The reciprocal-negative group is defined by the chromosome breaking in the empty stretch just in front of the partner gene. But the gene sitting on the other side of that empty stretch, ACER1, turns up in the published list of genes that have been found joined to the back half of KMT2A - so at least one patient broke there and made a mirror-image fusion after all.
The same thing, for a scientist
The reciprocal-negative arm of KMT2A::MLLT1 is defined by breakpoints lying 5' of MLLT1 and 3' of **ACER1** [E1]. The recombinome's Supplementary Table S4A lists the 40 in-frame reciprocal fusion partner genes found in 426 complex KMT2A rearrangements, and **ACER1 is the first name on that list** [E2]. The same paper states that the in-frame reciprocal fusions were identified in complex rearrangements whose *direct* partner genes include MLLT1 [E2]. Put together, the ACER1-MLLT1 intergenic region - the region whose breaks define 'no reciprocal allele results' - has produced at least one in-frame reciprocal fusion carrying the KMT2A C-terminus. The premise that a spliced KMT2A::MLLT1 is reciprocal-fusion-free is therefore **usually** true and **not universally** true, and the exception is documented inside the very dataset the claim rests on.
The geometry, and why ACER1 is the gene that would appear
In a spliced KMT2A::MLLT1 the break falls in the intergenic stretch between ACER1 and MLLT1 on 19p13.3, so der(11) receives an intact MLLT1 and der(19) receives 3'-KMT2A abutting the ACER1 side of the break 1. If the break falls in the intergenic DNA, der(19) carries no coding sequence to fuse to and there is no reciprocal gene - the standard account 3. If it falls a little further 5', inside ACER1, then der(19) carries ACER1 exons joined to 3'-KMT2A, and if the frames line up an ACER1::KMT2A chimera results. That is a difference of a few kilobases in breakpoint position with a qualitative consequence, and it is the kind of thing a breakpoint class defined by 'upstream of exon 1' cannot see.
How firm is this, honestly
Firm on the fact, soft on the attribution. Fact: ACER1 is in the alphabetical list of 40 in-frame fused reciprocal TPGs in Supplementary Table S4A, read from the supplementary Word file of the recombinome, and it carries no '(2x)' marker so it is a single case 2. Fact: the direct partners of the complex rearrangements that produced those 40 in-frame reciprocal fusions are listed, and MLLT1 is among them 2. Not established: that the ACER1 case is one of the MLLT1 cases. The supplementary table is a flat alphabetical gene list with no patient-level linkage, so the connection is made here by genomic adjacency - ACER1 sits immediately 5' of MLLT1 at 19p13.3, and a break producing an in-frame ACER1::KMT2A reciprocal in any other context would require a separate translocation to 19p13.3 that is not the one under discussion. That is a strong argument and it is not a citation. One line from the source archive settles it and nothing else will.
What it does and does not do to the control arm
It does not dissolve the arm. One case against 153 is a contamination rate under 1% if the attribution is right, and any residual reciprocal-positive patients sitting inside the reciprocal-negative arm dilute a true effect rather than create a false one. What it does is remove the word 'by construction'. The graph has been saying that a spliced fusion produces no reciprocal allele as a matter of geometry rather than of measurement, and that is not quite right: it produces no reciprocal allele provided the break lands in the intergenic DNA rather than in the upstream gene. The correct statement is probabilistic and the probability has not been measured. Pair this with the converse error - patients with intra-MLLT1 breaks who are nonetheless reciprocal-negative because 3'-KMT2A was deleted 4 - and both arms of the comparison leak, in opposite directions, by unmeasured amounts.
The wider point about supplementary tables
This finding is not in the paper's text, its figures or its abstract. It is one gene name in an alphabetical list inside a 425 KB Word file attached to the supplementary archive, and it contradicts a sentence in the paper's own Results. It was found by fetching {PMCID}/supplementaryFiles, checking that the .docx began with the PK magic bytes rather than trusting the HTTP 200, and flattening word/document.xml to text. The archive is 1,027,204 bytes and the Word file 425,197 bytes uncompressed - both real, unlike the zero-byte member this project logged for PMC6880934.
| gene | ACER1 |
|---|---|
| locus | 19p13.3, immediately 5' of MLLT1 |
| role | listed among the 40 in-frame fused reciprocal KMT2A partner genes in Suppl. Table S4A of PMID 37019990 |
| occurrences | 1 |
| denominator complex rearrangements | 426 |
| attribution to mllt1 case | inferred from genomic adjacency, NOT established by the source |
| consequence | 'spliced fusion implies no reciprocal allele' is usually true, not true by construction |
| leak direction negative arm | reciprocal-positive patients may sit inside the reciprocal-negative arm (break inside ACER1) |
| leak direction positive arm | reciprocal-negative patients may sit inside the reciprocal-positive arm (3'-KMT2A deletion, out-of-frame junction) |
| how found | Europe PMC {PMCID}/supplementaryFiles -> 1,027,204-byte zip -> 41375_2023_1877_MOESM1_ESM.docx (425,197 bytes, PK magic bytes) -> word/document.xml flattened |
- A companion diagnostic that scores reciprocal status from breakpoint position would call an ACER1-break patient reciprocal-negative while they carry an in-frame reciprocal chimera, and would call a 3'-KMT2A-deleted patient reciprocal-positive while they carry none. Both errors are invisible to the assay that produced the label.
- Is the ACER1 in-frame reciprocal case a KMT2A::MLLT1 patient? One line from the DCAL archive settles it, and nothing in the published record does.
- What fraction of the 153 intergenic-break patients have breaks inside ACER1 rather than in the intergenic DNA? The breakpoint sequences exist; the question has never been asked.
- Does an ACER1::KMT2A product exist at the protein level, and would it behave like the other reciprocal products? ACER1 is an alkaline ceramidase - a metabolic enzyme with no chromatin role - so an ACER1::KMT2A chimera would be the KMT2A C-terminus with an essentially inert N-terminal tag, which is close to a natural experiment in what the reciprocal product's KMT2A half does on its own.
- E1strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper
Read in full text (PMC11246743): of 302 t(11;19) patients, 50.7% (n = 153) harbour genomic breaks 5' upstream of the MLLT1 gene but 3' downstream of ACER1, and another 33.4% (n = 101) harbour breaks within the first MLLT1 intron; ENL is composed of 12 exons and located on chromosome 19p13.3.
The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia. · Hu H, Saha N, Yang Y, Ahmad E, et al. · Leukemia 2023What this evidence cannot show
Read via the PMC HTML page after Europe PMC fullTextXML returned HTTP 500 and efetch db=pmc returned HTTP 429. The paper names ACER1 only as the 3' boundary of a breakpoint interval and makes no claim about reciprocal fusions to it.
Evidence that argues against this (1)
- The paper's own framing treats the 153 intergenic-break patients as a single class defined by YEATS retention, not by reciprocal status, so it neither supports nor contradicts the reciprocal reading placed on it here. Hu H et al. 2023
- E2strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper
Supplementary Table S4A of the 2023 KMT2A recombinome lists the 40 in-frame fused reciprocal translocation partner genes in alphabetical order, beginning: 'ACER1, ADARB2, APBB1IP, ATG16L2, ATP5MG, C11ORF65, CEP164 (2x), CEP164, DCP1A, DDX6...'; the main text states that these 40 in-frame and 219 out-of-frame reciprocal TPGs bearing the KMT2A C-terminus were identified in complex rearrangements with already known direct fusion partner genes, listing for the 40 in-frame fusions: ACNT2, AFDN, AFF1, AFF3, ELL, MLLT1, MLLT10, MLLT3, MLLT6 and SEPTIN6.
The KMT2A recombinome of acute leukemias in 2023. · Meyer C, Larghero P, Almeida Lopes B, et al. · Leukemia 2023What this evidence cannot show
The gene list was read from the supplementary archive, not from the article body: Europe PMC {PMCID}/supplementaryFiles for PMC10169636 returned a 1,027,204-byte zip whose member 41375_2023_1877_MOESM1_ESM.docx (425,197 bytes uncompressed, magic bytes PK) was unpacked and word/document.xml flattened to text on 2026-09-19. The table is alphabetical with NO patient-level linkage, so which direct partner each reciprocal gene belongs to is not recoverable from it. The attribution of the ACER1 case to a KMT2A::MLLT1 patient is this graph's inference from genomic adjacency and is explicitly NOT established by the source.
Evidence that argues against this (1)
- ACER1 carries no recurrence marker in the list, so this is n = 1 out of 426 complex rearrangements analysed; a single case cannot establish a rate, and complex rearrangements are themselves a selected subset in which unusual configurations are over-represented by definition. Meyer C et al. 2023
- E3strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper
Read in full text (PMC10169636): in spliced fusions the 5' portion of KMT2A is recombined upstream of an intact partner gene and transcripts from the KMT2A promoter read through into it, splicing to the partner's exon 2; for MLLT1, about 50% of breakpoints (n = 241 of 460) localise upstream of MLLT1 exon 1 and in these cases only KMT2A::MLLT1 transcripts and no reciprocal one are expressed.
The KMT2A recombinome of acute leukemias in 2023. · Meyer C, Larghero P, Almeida Lopes B, et al. · Leukemia 2023What this evidence cannot show
Read in full text via Europe PMC fullTextXML. The sentence is a general statement about the mechanism, attributed to a prior reference (PMID 17252016), and is not presented as the result of assaying reciprocal transcripts in all 241 patients.
Evidence that argues against this (1)
- The same paper's supplementary Table S4A lists ACER1 among in-frame reciprocal partners, which is inconsistent with treating every break in the ACER1-MLLT1 interval as reciprocal-free. Meyer C et al. 2023
- E4moderate confidence 3 of 5: One strong study, or several smaller consistent ones.paper
In a T-ALL with a cryptic t(11;19), MLL sequences distal to the breakpoint were deleted from the genome, precluding formation of a reciprocal ENL/MLL fusion protein.
Complex MLL rearrangement in a patient with T-cell acute lymphoblastic leukemia. · Chervinsky DS, Sait SN, Nowak NJ, et al. · Genes Chromosomes Cancer 1995What this evidence cannot show
Abstract only; no PMCID. n = 1.
Evidence that argues against this (1)
- The founding KMT2A paper reported a t(11;19) line expressing fusion transcripts from both derivative chromosomes, so intra-MLLT1 breaks do commonly give a reciprocal transcript and the deletion case is the exception, not the rule. Tkachuk DC et al. 1992
ACER1 is listed among in-frame reciprocal KMT2A partners, so the intergenic-break class is not reciprocal-free by construction
one documented leak in the reciprocal-negative arm